Annual EBITDA
$2.70B$82.00M+3.13%
Summary
- Current Value
- As of today, ALC annual EBITDA is $2.70B, up +3.13% on
- Historical Performance
- ALC annual EBITDA is up +28.22% over the past 3 years, up +67.74% over the past 5 years
- All-Time High Comparison
- ALC annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- ALC annual EBITDA is +28.22% above its 3-year low of $2.11B reached on an earlier date
- Sector Comparison
- ALC annual EBITDA is higher than 95.94% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $2.70B | +3.1% | +28.2% | +67.7% | – | |
| Quarterly EBITDA | $336.00M | -44.2% | -44.9% | -32.3% | – | |
| TTM EBITDA | $2.47B | -8.6% | +6.3% | +24.4% | – | |
| Price | $74.26 | -8.4% | -10.2% | -8.0% | – | |
| PE Ratio | 56.94 | +51.4% | -49.8% | -74.0% | – | |
| Annual Revenue | $10.40B | +4.9% | +19.3% | +52.2% | – | |
| Annual EPS | $1.98 | -3.5% | +191.5% | +281.9% | +100.0% | |
| $1.36B | -1.8% | +38.9% | +9842.9% | +100.0% | ||
| Annual Net Income | $980.00M | -3.7% | +192.5% | +284.6% | – |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.70B | at high | |
| 5Y | $2.70B | at high | |
| All | $2.70B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.11B | N/A | +28.2% |
| 5Y | $1.61B | N/A | +67.7% |
| All | $1.23B | +119.8% |
EBITDA History
FAQ
- What is the current annual EBITDA of ALC?
- As of today, ALC annual EBITDA is $2.70B
- What is 1-year change in ALC annual EBITDA?
- ALC annual EBITDA is up +3.13% year-over-year
- What is 3-year change in ALC annual EBITDA?
- ALC annual EBITDA is up +28.22% over the past 3 years
- How far is ALC annual EBITDA from its all-time high?
- ALC annual EBITDA is currently at its all-time high
- How does ALC annual EBITDA rank versus sector peers?
- ALC annual EBITDA is higher than 95.94% of companies in Healthcare sector
- When is ALC next annual earnings release?
- As of today, the next annual earnings release for ALC has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$336.00M$367.00M-52.20%
Summary
- Current Value
- As of today, ALC quarterly EBITDA is $336.00M, down -52.20% on
- Historical Performance
- ALC quarterly EBITDA is down -44.19% year-over-year, down -44.92% over the past 3 years
- All-Time High Comparison
- ALC quarterly EBITDA is currently -57.52% below its historical high of $791.00M set on
- 3-Year Low Comparison
- ALC quarterly EBITDA is at its 3-year low
- Sector Comparison
- ALC quarterly EBITDA is higher than 93.43% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $336.00M | -52.2% | -44.2% | -44.9% | -32.3% | |
| Annual EBITDA | $2.70B | – | +3.1% | +28.2% | +67.7% | |
| TTM EBITDA | $2.47B | -9.7% | -8.6% | +6.3% | +24.4% | |
| Price | $74.26 | +10.4% | -8.4% | -10.2% | -8.0% | |
| PE Ratio | 56.94 | +40.3% | +51.4% | -49.8% | -74.0% | |
| Quarterly Revenue | $2.82B | +4.3% | +8.7% | +16.6% | +33.8% | |
| Quarterly EPS | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| $48.00M | -88.5% | -83.0% | -84.6% | -80.8% | ||
| Quarterly Net Income | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $741.00M | -54.7% | |
| 3Y | $791.00M | -57.5% | |
| 5Y | $791.00M | -57.5% | |
| All | $791.00M | -57.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $336.00M | at low | |
| 3Y | $336.00M | at low | |
| 5Y | $336.00M | at low | |
| All | $71.00M | +373.2% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of ALC?
- As of today, ALC quarterly EBITDA is $336.00M
- What is ALC quarterly EBITDA most recent change?
- ALC quarterly EBITDA was down -52.20% on June 1, 2026
- What is 1-year change in ALC quarterly EBITDA?
- ALC quarterly EBITDA is down -44.19% year-over-year
- How far is ALC quarterly EBITDA from its all-time high?
- ALC quarterly EBITDA is currently -57.52% below its historical high of $791.00M set on March 31, 2025
- How does ALC quarterly EBITDA rank versus sector peers?
- ALC quarterly EBITDA is higher than 93.43% of companies in Healthcare sector
- When is ALC next earnings release?
- As of today, the next earnings release for ALC has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$2.47B$266.00M-9.74%
Summary
- Current Value
- As of today, ALC TTM EBITDA is $2.47B, down -9.74% on
- Historical Performance
- ALC TTM EBITDA is down -8.64% year-over-year, up +6.30% over the past 3 years
- All-Time High Comparison
- ALC TTM EBITDA is currently -12.56% below its historical high of $2.82B set on
- 3-Year Low Comparison
- ALC TTM EBITDA is +7.45% above its 3-year low of $2.29B reached on
- Sector Comparison
- ALC TTM EBITDA is higher than 95.62% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $2.47B | -9.7% | -8.6% | +6.3% | +24.4% | |
| Annual EBITDA | $2.70B | – | +3.1% | +28.2% | +67.7% | |
| Quarterly EBITDA | $336.00M | -52.2% | -44.2% | -44.9% | -32.3% | |
| Price | $74.26 | +10.4% | -8.4% | -10.2% | -8.0% | |
| PE Ratio | 56.94 | +40.3% | +51.4% | -49.8% | -74.0% | |
| TTM Revenue | $10.86B | +2.1% | +8.3% | +19.6% | +38.9% | |
| TTM EPS | $1.30 | -21.3% | -39.5% | +78.8% | +253.3% | |
| $1.19B | -16.5% | -18.1% | +0.5% | +78.5% | ||
| TTM Net Income | $643.00M | -21.5% | -40.1% | +77.6% | +251.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.82B | -12.6% | |
| 3Y | $2.82B | -12.6% | |
| 5Y | $2.82B | -12.6% | |
| All | $2.82B | -12.6% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.47B | at low | |
| 3Y | $2.29B | +7.5% | |
| 5Y | $1.98B | N/A | +24.4% |
| All | $260.00M | +848.1% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of ALC?
- As of today, ALC TTM EBITDA is $2.47B
- What is ALC TTM EBITDA most recent change?
- ALC TTM EBITDA was down -9.74% on June 1, 2026
- What is 1-year change in ALC TTM EBITDA?
- ALC TTM EBITDA is down -8.64% year-over-year
- How far is ALC TTM EBITDA from its all-time high?
- ALC TTM EBITDA is currently -12.56% below its historical high of $2.82B set on December 1, 2025
- How does ALC TTM EBITDA rank versus sector peers?
- ALC TTM EBITDA is higher than 95.62% of companies in Healthcare sector
- When is ALC next earnings release?
- As of today, the next earnings release for ALC has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ALC Official Website www.alcon.com
- ALC Profile on Yahoo Finance finance.yahoo.com/quote/ALC
- ALC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/alc
